The United States plans to implement a 100% tariff on imports of branded or patented pharmaceutical products starting October 1. This announcement was made by President Donald Trump on Thursday. The tariffs will not apply to pharmaceutical companies that are in the process of building manufacturing plants in the U.S. Trump stated, "There will, therefore, be no Tariff on these pharmaceutical products if construction has started."

In addition to the pharmaceutical tariffs, the U.S. will also impose a 25% tariff on heavy-duty trucks and a 50% tariff on kitchen cabinets. These measures are part of the administration's broader strategy to encourage domestic manufacturing and reduce reliance on foreign products.

The tariffs on pharmaceuticals are expected to impact the pricing and availability of various medications in the U.S. market. The administration's focus on tariffs reflects ongoing concerns about trade imbalances and the need to bolster American manufacturing capabilities.